Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Eltrombopag raises platelet count in 2 weeks in patients with HCv and significant thrombocytopenia

Eltrombopag raises platelet count in 2 weeks in patients with HCv and significant thrombocytopenia. Hepatology. 2007; 46:252A.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.